Clinical Trials Directory

Trials / Completed

CompletedNCT07433465

Early Pregnancy Serum Ferritin Levels as a Predictor for Gestational Diabetes Mellitus

High Serum Ferritin Early in Pregnancy May Predict the Development of Gestational Diabetes Later.

Status
Completed
Phase
Study type
Observational
Enrollment
556 (actual)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This prospective study evaluates a target population of pregnant women at the time of pregnancy diagnosis to investigate the predictive value of serum ferritin (SF) levels for the later development of gestational diabetes mellitus (GDM). The intervention involves measuring early-pregnancy SF, transferrin, and hemoglobin levels, alongside HbA1c, and comparing these biomarkers between women who later develop GDM and those who remain normoglycemic. The primary outcome is to assess the success rate of this diagnostic regimen in identifying high-risk individuals, aiming to establish SF as a valuable early biomarker for GDM to enable timely interventions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGlycemic MarkersFasting blood glucose (FBG), 2-h Post postprandial blood glucose (PPBG), HbA1c, and Fasting Serum Insulin (FSI).

Timeline

Start date
2022-12-05
Primary completion
2024-12-07
Completion
2025-10-10
First posted
2026-02-25
Last updated
2026-02-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07433465. Inclusion in this directory is not an endorsement.